Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
osimertinib
×
30 days
×
Clear all
Filters
3
NCT04606771
2026-02-27
CoC
AstraZeneca
Phase 2
Active not recruiting
30 enrolled
20 charts